scholarly journals Metasztázis miatt végzett máj- és hasfalreszekció 11 évvel a pancreatoduodenectomia után

2017 ◽  
Vol 158 (28) ◽  
pp. 1109-1111
Author(s):  
Zsanett Biró ◽  
Róbert Papp ◽  
Levente Kucserik ◽  
Yousuf Al-Farhat ◽  
András Fincsúr ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Case Report ◽  
Liver Metastasis ◽  
Male Patient ◽  
Disease Recurrence ◽  
Redo Surgery ◽  
History Of ◽  
Solitary Liver ◽  
Solitary Liver Metastasis

Abstract: Pancreatic cancer has adverse prognosis. Disease recurrence is typical and it occurs mainly within the first 2 years postoperatively. However late and soliter metastases are rare. This case report shows the history of a male patient, who was radically operated on for pancreatic cancer. 11 years later a solitary liver metastasis has developed and it was completely removed by resection. 1 year postoperatively the patient is doing well. Our case demonstrates that in patients after resection for pancreatic cancer, redo surgery might be justified in case of late and isolated metastasis. Orv Hetil. 2017; 158(28): 1109–1111.

scholarly journals Hepatectomy for rapidly growing solitary liver metastasis from non-small cell lung cancer: a case report

2019 ◽  
Vol 5 (1) ◽  
Author(s):  
Hiroyuki Hakoda ◽  
Yasuharu Sekine ◽  
Hideo Ichimura ◽  
Kazumitsu Ueda ◽  
Shigeo Aoki ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Case Report ◽  
Liver Metastasis ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Solitary Liver ◽  
Solitary Liver Metastasis

scholarly journals Metastatic Pancreatic Cancer with BRAF and P53 Mutations: Case Report of Therapeutic Response to Doublet Targeted Therapy

2020 ◽  
Vol 13 (3) ◽  
pp. 1239-1243
Author(s):  
Shenthol Sasankan ◽  
Lorraine Rebuck ◽  
Gloria Darrah ◽  
Moises Harari Turquie ◽  
Ian Rabinowitz
Keyword(s):  
Pancreatic Cancer ◽  
Case Report ◽  
Targeted Therapy ◽  
Therapeutic Response ◽  
Case Reports ◽  
Clinical History ◽  
P53 Mutation ◽  
Metastatic Pancreatic Cancer ◽  
First Case ◽  
History Of

We report on the clinical history of a 49-year-old female with metastatic pancreatic cancer. She was initially treated with standard chemotherapy as per current guidelines. She was found to have both a BRAF and P53 mutation, and received dabrafenib and trametinib with deep responses, both radiographically and biochemically (CA19-9). Her response has been more clinically relevant than responses in previous case reports of patients with BRAF-positive pancreatic cancer treated with targeted therapy. To the best of our knowledge, this is the first case report showing a dramatic therapeutic response to combination therapy with dabrafenib and trametinib in metastatic pancreatic cancer.

Analysis of prognostic factors after resection of solitary liver metastasis in colorectal cancer: a 22-year bicentre study

2018 ◽  
Vol 144 (3) ◽  
pp. 593-599 ◽  
Author(s):  
Sara Acciuffi ◽  
Frank Meyer ◽  
Astrid Bauschke ◽  
Utz Settmacher ◽  
Hans Lippert ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Prognostic Factors ◽  
Liver Metastasis ◽  
Solitary Liver ◽  
Solitary Liver Metastasis
Sign in / Sign up

Export Citation Format

Share Document